Cannabis Lobbyists Speak for the Industry

The biggest challenge facing lobbyists is understanding their audience. On the federal level, Macias challenges cannabis lobbyists to know who in Congress is a “key champion for cannabis.” After they are identified, a lobbyist should familiarize themselves with the individual perspectives of those politicians. That knowledge will assist a lobbyist in adapting their client’s message to appeal to each politician’s sensitivities. 

What Does a Lobbyist Do?

Each state defines lobbying for itself, but the consensus is that a lobbyist attempts to influence government action, according to the National Conference of State Legislatures (NCSL). The NCSL further defines a lobbyist as an employed person who is paid to try and persuade politicians to vote one way or another on a piece of pending legislation. 

“My job is to help my clients figure out their goals and then develop a strategy to accomplish that goal,” Robinson said. Clients should be aware that strategies and agendas can change over time based on feedback, he added. 

“Negotiations are a big part of my work, even with a client,” Robinson noted. “We need to manage expectations and timelines. A lot of times, a client wants things to happen immediately, so being upfront about realistic timelines and goals is imperative for a positive professional relationship between myself and my clients.”

In Macias’s mind, lobbyists “look at primary issues facing our industry and the patients we serve.” She urges lobbyists to “understand and respect why you want your voice heard in a particular way.”

Cannabis Opponents

According to Macias, some anti-cannabis lobbying groups are not merely anti-cannabis. The pharmaceutical industry, for one, is against marijuana because it wants patients to continue needing the prescription medicines they manufacture and sell. 

“Pharmaceutical companies do not want anyone to manufacture anything that works better than their drugs,” she said. The alcohol and beer industries also oppose cannabis because they do not want anything altering American minds besides booze. 

Macias noted, “Pfizer knows cannabis is getting in position by buying prescription companies that are already using cannabis as an ingredient.” 

Washington and Colorado were the first states to legalize recreational cannabis in 2012. However, counters Macias, the pharmaceutical industry has been lobbying for decades, so “their roots are pretty deep in our Congress. Cannabis has been in there for ten solid years, except for California, and we’ve really only started to organize.”

Diversity in Cannabis Lobbying

Macias not only talks the talk, but she also walks the walk. Known as a cannabis pioneer, she became the country’s first Black woman medical cannabis operator when she opened her D.C. dispensary in 2015. She has been a champion of women and minorities throughout her entire career. 

When Macias hires a federal lobbyist, she takes care to find a female who represents someone like her. “Women are underrepresented in the lobbying world and cannabis, she said. But just because we aren’t there, doesn’t mean we should stop seeking a seat at the table. We need more women speaking out about the true female experience in both the business and everyday worlds.”

This article first appeared in Volume 4 Issue 3 of Cannabis & Tech Today.